409 related articles for article (PubMed ID: 19295333)
21. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S; Padmapriyadarsini C; Venkatesan P; Narendran G; Ramesh Kumar S; Iliayas S; Menon PA; Selvaraju S; Pooranagangadevi NP; Bhavani PK; Ponnuraja C; Dilip M; Ramachandran R
Clin Infect Dis; 2011 Oct; 53(7):716-24. PubMed ID: 21890776
[TBL] [Abstract][Full Text] [Related]
23. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
[TBL] [Abstract][Full Text] [Related]
25. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
[TBL] [Abstract][Full Text] [Related]
27. Improving survival with tuberculosis & HIV treatment integration: A mini-review.
Naidoo K; Rampersad S; Karim SA
Indian J Med Res; 2019 Aug; 150(2):131-138. PubMed ID: 31670268
[TBL] [Abstract][Full Text] [Related]
28. Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan.
Shafiq M; Zafar S; Ahmad A; Kazmi A; Fatima A; Mujahid TA; Qazi R; Akhter N; Shahzad A; Rehman SU; Shereen MA; Hyder MZ
Biomed Res Int; 2023; 2023():4187488. PubMed ID: 37124927
[TBL] [Abstract][Full Text] [Related]
29. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
[TBL] [Abstract][Full Text] [Related]
30. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
[TBL] [Abstract][Full Text] [Related]
31. Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa.
Murphy RA; France H; Sunpath H; Gordon ML; Marconi VC; Kuritzkes DR; McIntosh K
J Trop Pediatr; 2009 Feb; 55(1):60-2. PubMed ID: 18786985
[TBL] [Abstract][Full Text] [Related]
32. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
[TBL] [Abstract][Full Text] [Related]
33. Impact of integrating HIV and TB care and treatment in a regional tuberculosis hospital in rural Guatemala.
Ikeda JM; Tellez CA; Hudes ES; Page K; Evans J; Racancoj O; Hearst N
AIDS Behav; 2014 Jan; 18 Suppl 1():S96-103. PubMed ID: 23959143
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
Yende-Zuma N; Naidoo K
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.
Takuva S; Westreich D; Menezes CN; McNamara L; Sanne I; Page-Shipp L; Maskew M
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1358-64. PubMed ID: 22863288
[TBL] [Abstract][Full Text] [Related]
37. The tuberculosis challenge in a rural South African HIV programme.
Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML
BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
[TBL] [Abstract][Full Text] [Related]
39. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah TA; Ncayiyana JR; Nyasulu PS
Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
[TBL] [Abstract][Full Text] [Related]
40. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
